Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bugelski, Peter J.
71  Ergebnisse:
Personensuche X
?
1

Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotox..:

Aligo, Jason ; Walker, Mindi ; Bugelski, Peter.
Journal of Immunotoxicology.  12 (2014)  1 - p. 1-15 , 2014
Link: https://doi.org/10.3109/..
 
?
2

Loss of toll-like receptor 3 function improves glucose tole..:

Wu, Linda H. ; Huang, C. Chris ; Adhikarakunnathu, Sree...
Metabolism.  61 (2012)  11 - p. 1633-1645 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Concordance of preclinical and clinical pharmacology and to..:

Martin, Pauline L ; Bugelski, Peter J
British Journal of Pharmacology.  166 (2012)  3 - p. 806-822 , 2012
Link: https://doi.org/10.1111/..
 
?
4

Concordance of preclinical and clinical pharmacology and to..:

Bugelski, Peter J ; Martin, Pauline L
British Journal of Pharmacology.  166 (2012)  3 - p. 823-846 , 2012
Link: https://doi.org/10.1111/..
 
?
5

Development of a murine model of lymph node metastases suit..:

Egenolf, Devon D. ; Rafferty, Patricia ; Brosnan, Kerry...
Journal of Pharmacological and Toxicological Methods.  63 (2011)  3 - p. 236-249 , 2011
Link: https://doi.org/10.1016/..
 
?
6

Pharmacodynamics of CNTO 530 and Darbepoetin-α in Human TNF..:

Achuthanandam, Ram ; Makropoulos, Dorie ; Johns, Laura...
Pharmacology & Pharmacy.  2 (2011)  1 - p. 17-30 , 2011
Link: https://doi.org/10.4236/..
 
?
7

Development of a human whole blood assay for prediction of ..:

Walker, Mindi R. ; Makropoulos, Dorie A. ; Achuthanandam, Ram..
International Immunopharmacology.  11 (2011)  11 - p. 1697-1705 , 2011
Link: https://doi.org/10.1016/..
 
?
8

A Novel EPO Receptor Agonist Improves Glucose Tolerance via..:

Scully, Michael S. ; Ort, Tatiana A. ; James, Ian E....
Experimental Diabetes Research.  2011 (2011)  - p. 1-10 , 2011
Link: https://doi.org/10.1155/..
 
?
9

Critical Review of Preclinical Approaches to Evaluate the P..:

Bugelski, Peter J. ; Volk, Amy ; Walker, Mindi R....
International Journal of Toxicology.  29 (2010)  5 - p. 435-466 , 2010
Link: https://doi.org/10.1177/..
 
?
10

Development of a murine model of tumor promotion and progre..:

Egenolf, Devon ; Rafferty, Patricia ; Brosnan, Kerry...
The FASEB Journal.  24 (2010)  S1 - p. , 2010
Link: https://doi.org/10.1096/..
 
?
11

Activity of CNTO 530 in a murine model of sickle cell anemi:

Makropoulos, Dorie Ann ; Achuthanandam, Ram ; Rafferty, Patricia...
The FASEB Journal.  24 (2010)  S1 - p. , 2010
Link: https://doi.org/10.1096/..
 
?
12

Long-term activation of TLR3 by Poly(I:C) induces inflammat..:

Stowell, Nicole C ; Seideman, Jonathan ; Raymond, Holly A...
Respiratory Research.  10 (2009)  1 - p. , 2009
Link: https://doi.org/10.1186/..
 
?
13

Histologic characterization of a breast adenocarcinoma expe..:

Egenolf, Devon D ; Rafferty, Patricia ; Wiley, Diana...
The FASEB Journal.  23 (2009)  S1 - p. , 2009
Link: https://doi.org/10.1096/..
 
?
14

Anti‐CXCL13 and anti‐TNFαcombination therapy in a mouse mod..:

Gardner, Debra Bryce ; Bassiri, Ashlyn ; Bugelski, Peter..
The FASEB Journal.  22 (2008)  S2 - p. 473-473 , 2008
Link: https://doi.org/10.1096/..
 
?
15

Alternative Animal Models for Immunomodulation and Immunoto..:

, In: Immunotoxicology Strategies for Pharmaceutical Safety Assessment,
Bugelski, Peter J. - p. 319-343 , 2008
Link: https://doi.org/10.1002/..
 
1-15